STOCK TITAN

Liquidia to Report Second Quarter 2021 Financial Results on August 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Liquidia Corporation (NASDAQ: LQDA) will report its second quarter 2021 financial results on August 10, 2021. A conference call and webcast are scheduled for 8:30 a.m. EDT, where the company will discuss financial outcomes and provide a corporate update. Interested parties can access the call via telephone or the webcast available on Liquidia's website. The company focuses on developing treatments for pulmonary hypertension through its PRINT® Technology, with ongoing projects like LIQ861 and Treprostinil Injection.

Positive
  • Scheduled financial results announcement on August 10, 2021.
  • Plans to provide a corporate update during the conference call.
Negative
  • None.

MORRISVILLE, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its second quarter 2021 financial results on Tuesday, August 10, 2021. The company will host a webcast and conference call at 8:30 a.m. Eastern Daylight Time to discuss financial results and provide a corporate update.

The live call may be accessed by dialing 1-877-707-8711 (domestic) or 1-857-270-6219 (international) and entering the conference code: 4638099. A webcast of the call will be available and archived on Liquidia’s website at https://liquidia.com/index.php/investors/events-and-presentations.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies is developing LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of PAH. Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as Treprostinil Injection. For more information, please visit www.liquidia.com.

Contact Information

Media & Investors:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com


FAQ

When will Liquidia report its second quarter 2021 financial results?

Liquidia will report its second quarter 2021 financial results on August 10, 2021.

What time is Liquidia's financial results conference call?

The conference call is scheduled for 8:30 a.m. Eastern Daylight Time.

How can I access Liquidia's financial results call?

You can access the call by dialing 1-877-707-8711 for domestic calls or 1-857-270-6219 for international calls.

What is Liquidia's focus area in biopharmaceuticals?

Liquidia focuses on developing treatments for pulmonary hypertension and utilizes its PRINT® Technology.

Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Stock Data

912.38M
60.46M
19.49%
54.31%
12.25%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MORRISVILLE